Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

OUR GOAL

With your help, we will create a $10 million endowment to seed the boldest research ideas in the interdisciplinary labs under the direction of Robert H. Brown Jr., DPhil, MD, one of the world's foremost authorities on amyotrophic lateral sclerosis (ALS).

marathon generic 250w.png

Boston Marathon 2020

Members of your 2020 UMass ALS Cellucci Fund team are as dedicated today as they have ever been to raise money to support ALS research at the University of Massachusetts Medical School. Details about how they will participate in this year's virtual event to come soon.

You can help!

Support the team

brown-robert 250x225.png

ALS Phase II clinical trial led by Robert Brown shows treatment is safe, well tolerated

A study by Robert H. Brown Jr., MD, DPhil, published in the journal Neurology, shows that a single transplantation of a bone marrow-derived mesenchymal stem cell treatment for amyotrophic lateral sclerosis (ALS) called NurOwn was safe and well tolerated by patients.

Read more
Page Menu